Loading provider…
Loading provider…
Gynecologic Oncology Physician in Boston, MA
NPI: 1093772782Primary Practice Location
BRIGHAM AND WOMEN'S HOSPITAL
75 Francis St, Boston, MA
Primary Employer
Brigham & Womens Physicians Organization Inc
brighamandwomens.org
HQ Phone
Get MD Ross's Phone Numberphone_androidMobile
Get MD Ross's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
NH State Medical License
2022 - 2026
RI State Medical License
2021 - 2026
VT State Medical License
2022 - 2026
CT State Medical License
2022 - 2025
MA State Medical License
1978 - 2025
ME State Medical License
2022 - 2025

American Board of Obstetrics and Gynecology
Obstetrics & Gynecology

American Board of Obstetrics and Gynecology
Gynecologic Oncology
Boston University School Of Medicine
bumc.bu.edu
Medical School
Until 1973
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
Fellowship • Hematology and Medical Oncology
1978 - 1980
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital
Residency • Obstetrics and Gynecology
1975 - 1978
Mass General Brigham/Brigham and Women's Hospital
Residency • Surgery
1973 - 1975
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 71 | 88 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 71 | 81 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 52 | 52 |
| 4 | 99443Physician telephone patient service, 21-30 minutes of medical discussion | 13 | 14 |
Pretreatment curettage—A predictor of chemotherapy response in gestational trophoblastic neoplasia
Authors: Ross S. Berkowitz, Usha Desai, Donald P. Goldstein, Shirley G. Driscoll, A R Marean, Marilyn R. Bernstein
Publication Date: 1980-08
Authors: Choi, Pui-Wah, Yang, Junzheng, Ng, Shu-Kay, Feltmate, Colleen, Muto, Michael G, Hasselblatt, Kathleen, Lafferty-Whyte, Kyle, JeBailey, Lellean, MacConaill, Laura, Welch, William R, Fong, Wing-Ping, Berkowitz, Ross S, Ng, Shu-Wing
Journal: Oncotarget
Lead Sponsor: Beth Israel Deaconess Medical Center
Collaborators: National Cancer Institute (NCI), Massachusetts General Hospital, Dana-Farber Cancer Institute
Intervention / Treatment: PROCEDURE: Tumor collection
Lead Sponsor: Beth Israel Deaconess Medical Center
Collaborators: National Cancer Institute (NCI), Massachusetts General Hospital, Brigham and Women's Hospital, Dana-Farber Cancer Institute
Intervention / Treatment: DRUG: GM-CSF, DRUG: imiquimod, BIOLOGICAL: Dendritic Cell/Tumor Fusion Vaccine